Clinical Trials Logo

Clinical Trial Summary

Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01296620
Study type Interventional
Source Tranzyme, Inc.
Contact
Status Completed
Phase Phase 3
Start date February 2011
Completion date March 2012

See also
  Status Clinical Trial Phase
Completed NCT01285570 - Ulimorelin Study of Efficacy and Safety (ULISES 007) Phase 3
Withdrawn NCT04872452 - Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders N/A
Completed NCT04880538 - Enteric Neural Precursor Cells (ENPC) in the Human Gut
Completed NCT01280344 - Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function Phase 2